PJ Barrett-Lee, JM Dixon, C Farrell, A Jones… - Annals of oncology, 2009 - Elsevier
Anthracyclines are considered to be among the most active agents for the treatment of
breast cancer. However, their use is limited by cumulative, dose-related cardiotoxicity. Such …